Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study
1 other identifier
interventional
8
1 country
1
Brief Summary
The American Association of Oral and Maxillofacial Surgeons estimated that 69% of adults ages 35 to 44 have lost at least one permanent tooth. Dental implants have revolutionized dentistry by providing tooth-like replacement for missing teeth and a solution that is predictable with long-term success.. After the implant is placed, natural bacteria from the mouth can develop around implants just like around natural teeth. Studies have shown that bacterial contamination can cause peri-implantitis- gum disease or inflammation around the implant, eventually leading to bone loss. Removing bacteria from dental implant surfaces can prevent peri-implantitis, and surface debridement constitutes the basis of treatment of peri-implant disease. Typically, mechanical hand instrumentation using curettes to remove biofilm and calculus is the main basis for periodontal therapy. However, total debridement is difficult, and the hand tools may damage the surface of the implant and making it more plaque retentive. Studies have shown that mechanical non-surgical therapy alone is not sufficient to treat peri-implantitis. There is evidence that a dental laser may be an effective method to remove bacteria from implant surfaces, with less damage to the surface. One type of dental laser, Er:YAG, appears optimal for implant decontamination as the Er:YAG laser energy is primarily absorbed by water, resulting in vaporization of bacteria and minimal surface alterations on the implant surface.The aim of this study is to evaluate the efficiency of biofilm decontamination of Er:YAG laser compared to carbon fiber curette.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2017
CompletedFirst Posted
Study publicly available on registry
April 4, 2017
CompletedStudy Start
First participant enrolled
April 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2018
CompletedResults Posted
Study results publicly available
March 31, 2023
CompletedMarch 31, 2023
March 1, 2023
1.5 years
March 29, 2017
February 18, 2022
March 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Percent Bacteria Biofilm
Percent area of the titanium disc covered by bacteria biofilm
3 days
Study Arms (4)
Er:YAG Laser
EXPERIMENTALEr:YAG Laser only
Carbon Fiber Curette
ACTIVE COMPARATORCarbon fiber curette only
Er:YAG Laser + Carbon Fiber Curette
EXPERIMENTALCombination of Er:YAG Laser and carbon fiber curette
No Treatment
NO INTERVENTIONNo treatment (control)
Interventions
Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.
Titanium disks will be decontaminated ex-vivo with carbon fiber curettes
Eligibility Criteria
You may qualify if:
- Presence of enough teeth to support the mouth guard.
- Subjects diagnosed with clinical health, gingivitis, or slight chronic periodontitis defined as periodontal inflammation with slight (1-2mm) attachment loss.
You may not qualify if:
- Subjects with insufficient dental support for the mouth guard
- Subjects diagnosed with moderate or severe chronic periodontitis.
- Subjects with known allergy to acrylic or titanium.
- Subjects who smoke cigarettes, cigars, snuff tobacco, or any other form of smoking.
- Subjects with a history of antibiotic treatment within the last six months.
- Subjects with contraindications to wearing a mouth guard, such as chronic obstructive pulmonary disease or severe sleep apnea.
- Subjects with uncontrolled or debilitating medical conditions, including but not limited to subjects with uncontrolled diabetes, hematologic disorders, cancers, immunosuppression, severe cardiovascular disease, or uncontrolled thyroid disease
- Subjects that are currently pregnant according to self-report
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Universitylead
Study Sites (1)
Tufts University School of Dental Medicine
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Robert Gyurko
- Organization
- Tufts University
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Gyurko, DMD, PhD
TUSDM
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 29, 2017
First Posted
April 4, 2017
Study Start
April 20, 2017
Primary Completion
October 18, 2018
Study Completion
October 18, 2018
Last Updated
March 31, 2023
Results First Posted
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share